2024-12-18 IDOPRESS
JAKARTA,Indonesia,Dec. 16,2024 -- PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) proudly announces the distribution of an interim dividend to shareholders as part of its 129th Anniversary celebration. This demonstrates BRI's commitment to delivering economic value to its shareholders while commemorating its contribution to Indonesia's economy.

PT Bank Rakyat Indonesia (Persero) Tbk Celebrates Its 129th Anniversary
According to the company's public disclosure,based on the financial statements ending September 30,2024,the company will distribute an interim dividend for the 2024 fiscal year of Rp135 (One Hundred Thirty-Five Rupiah) per share,totalling Rp20.46 trillion. Of this amount,Rp10.88 trillion will be allocated to the Government of Indonesia,while up to Rp9.58 trillion will go to public shareholders.
Schedule and Procedures for Interim Dividend Distribution:
No.
Description
Date
1
Announcement of Schedule and Procedures
December 16,2024
2
End of Share Trading Period with Dividend Rights (Cum Dividend):
Regular & Negotiated Markets
Cash Market
December 24,2024
December 30,2024
3
Start of Share Trading Period Without Dividend Rights (Ex-
Dividend):
Regular and Negotiated Markets
Cash Market
December 27,2024
January 2,2025
4
Record Date for Eligible Shareholders
December 30,2024
5
Interim Dividend Payment
January 15,2025
BRI President Director,Sunarsostated that the interim dividend distribution reflects BRI's healthy performance and its appreciation for shareholders who have supported the bank's 129-year journey.
He emphasized that the interim dividend distribution will not affect BRI's capital adequacy. "All investment needs have been met,and sufficient reserves have been allocated to cover potential risks," Sunarso added.
As of the end of Q3 2024,BRI recorded a consolidated net profit of Rp45.36 trillion. In terms of intermediation,BRI disbursed Rp1,353.36 trillion in loans by the end of September 2024,representing a year-on-year (YoY) growth of 8.21%. Notably,81.70% of these loans,or approximately Rp1,105.70 trillion,were directed to the MSME (Micro,Small,and Medium Enterprises) segment. This growth also drove BRI's assets to grow 5.94% YoY,reaching Rp1,961.92 trillion.
Additionally,BRI maintained strong asset quality,as demonstrated by the improvement in its Non-Performing Loan (NPL) ratio,which stood at 2.90% in Q3 2024,down from 3.07% in the same period last year. The Loan at Risk (LAR) ratio also improved,declining from 13.80% in Q3 2023 to 11.66% in Q3 2024.
For more information on BRI,please visit www.bri.co.id
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map